Cardiac resynchronization therapy for the treatment of heart failure

References

• McMurray JJ, Pfeffer MA. Heart failure. Lancet365, 1877–1889 (2005).
   PubMed Web of Science ®Google Scholar
• Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. The current cost of heart failure to the National Health Service in the UK. Eur. J. Heart Fail.4(3), 361–371 (2002).
   PubMed Web of Science ®Google Scholar
• Rosamond W, Flegal K, Furie K et al. Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation117(4), e25–e146 (2008).
   PubMed Web of Science ®Google Scholar
• Grines CL, Bashore TM, Boudoulas H, Olson S, Shafer P, Wooley CF. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation79, 845–853 (1989).
   PubMed Web of Science ®Google Scholar
• Tanabe A, Mohri T, Ohga M et al. The effects of pacing-induced left bundle branch block on left ventricular systolic and diastolic performances. Jpn. Heart J.31(3), 309–317 (1990).
   PubMedGoogle Scholar
• Masoudi FA, Havranek EP, Smith G et al. Gender, age, and heart failure with preserved left ventricular systolic function. J. Am. Coll. Cardiol.41(2), 217–223 (2003).
   PubMed Web of Science ®Google Scholar
• Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation95(12), 2660–2667 (1997).
   PubMed Web of Science ®Google Scholar
• Nicol ED, Fittall B, Roughton M, Cleland JG, Dargie H, Cowie MR. NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland. Heart94(2), 172–177 (2008).
   PubMed Web of Science ®Google Scholar
• Shamim W, Yousufuddin M, Cicoria M, Gibson DG, Coats AJ, Henein MY. Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart88(1), 47–51 (2002).
   PubMed Web of Science ®Google Scholar
• Richardson M, Freemantle N, Calvert MJ, Cleland JG, Tavazzi L. Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial. Eur. Heart J.28(15), 1827–1834 (2007).
   PubMed Web of Science ®Google Scholar
• Gorcsan J 3rd, Abraham T, Agler DA et al. Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting – a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J. Am. Soc. Echocardiogr.21(3), 191–213 (2008).
   PubMed Web of Science ®Google Scholar
• Duncan AM, Lim E, Clague J, Gibson DG, Henein MY. Comparison of segmental and global markers of dyssynchrony in predicting clinical response to cardiac resynchronization. Eur. Heart J.27(20), 2426–2432 (2006).
   PubMed Web of Science ®Google Scholar
• Burkhoff D, Oikawa RY, Sagawa K. Influence of pacing site on canine left ventricular contraction. Am. J. Physiol.251(2 Pt 2), H428–H435 (1986).
   Google Scholar
• Xiao HB, Lee CH, Gibson DG. Effect of left bundle branch block on diastolic function in dilated cardiomyopathy. Br. Heart J.66(6), 443–447 (1991).
   PubMedGoogle Scholar
• Cazeau S, Ritter P, Bakdach S et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin. Electrophysiol.17, 1974–1979 (1994).
   PubMed Web of Science ®Google Scholar
• Auricchio A, Stellbrink C, Block M et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. Circulation99(23), 2993–3001 (1999).
   PubMed Web of Science ®Google Scholar
• Auricchio A, Stellbrink C, Sack S et al.; for The Pacing Therapies in Congestive Heart Failure (PATH-CHF) study group: Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J. Am. Coll. Cardiol.39(12), 2026–2033 (2002).
   PubMed Web of Science ®Google Scholar
• Cazeau S, Leclercq C, Lavergne T et al.; for The Multisite Stimulation in Cardiomyopathies (MUSTIC) study investigators: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N. Engl. J. Med.344(12), 873–880 (2001).
   PubMed Web of Science ®Google Scholar
• Abraham WT, Fisher WG, Smith AL et al.; for The Multicenter InSync Randomised Clinical Evaluation (MIRACLE) study group. Cardiac resynchronization in chronic heart failure. N. Engl. J. Med.346(24), 1845–1853 (2002).
   PubMed Web of Science ®Google Scholar
• Young JB, Abraham WT, Smith AL et al.; The Multicenter InSync ICD Randomised Clinical Evaluation (MIRACLE ICD) trial investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. J. Am. Med. Assoc.289(20), 2685–2694 (2003).
   PubMed Web of Science ®Google Scholar
• Higgins SL, Hummel JD, Niazi IK et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J. Am. Coll. Cardiol.42(8), 1454–1459 (2003).
   PubMed Web of Science ®Google Scholar
• Bristow MR, Saxon LA, Boehmer J et al.; for The Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med.350(21), 40–50 (2004).
   Google Scholar
• Cleland JG, Daubert JC, Erdmann E et al.; for the Cardiac Resynchronization-Heart Failure (CARE-HF) study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med.352(15), 1539–1549 (2005).
   PubMed Web of Science ®Google Scholar
• Cleland JG, Daubert JC, Erdmann E et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the Cardiac Resynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur. Heart J.27(16), 1928–1932 (2006).
   PubMed Web of Science ®Google Scholar
• McAlister FA, Ezekowitz J, Hooton N et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. J. Am. Med. Assoc.297(22), 2502–2514 (2007).
   PubMed Web of Science ®Google Scholar
• Yu CM, Lin H, Zhang Q et al. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart89, 54–60 (2003).
   PubMed Web of Science ®Google Scholar
• Beshai JF, Grimm RA, Nagueh SF et al. RETHINQ Study Investigators. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N. Engl. J. Med.357(24), 2461–2471 (2007).
   PubMed Web of Science ®Google Scholar
• Chung ES, Leon AR, Tavazzi L et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation117, 2608–2616 (2008).
   PubMed Web of Science ®Google Scholar
• Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am. J. Cardiol.91(6A), 2D–8D (2003).
   PubMed Web of Science ®Google Scholar
• Kamath GS, Steinberg JS. Cardiac resynchronization therapy and atrial fibrillation. Cardiol. J.16(1), 4–10 (2009).
   PubMed Web of Science ®Google Scholar
• Khadjooi K, Foley PW, Chalil S et al. Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation. Heart94, 879–883 (2008).
   PubMed Web of Science ®Google Scholar
• Tolosana JM, Madrid AH, Brugada J et al.; for The Spanish Atrial Fibrillation and Resynchronization (SPARE) investigators. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm. Am. J. Cardiol.102, 444–449 (2008).
   PubMed Web of Science ®Google Scholar
• Upadhyay GA, Choudhry NK, Auricchio A et al. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J. Am. Coll. Cardiol.52(15), 1239–1246 (2008).
   PubMed Web of Science ®Google Scholar
• Leclercq C, Walker S, Linde C et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur. Heart J.23(22), 1780–1787 (2002).
   PubMed Web of Science ®Google Scholar
• Hoppe UC, Casares JM, Eiskjaer H et al. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation114(1), 18–25 (2006).
   PubMedGoogle Scholar
• Ferreira AM, Adragao P, Cavaco DM et al. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation. Europace10, 809–815 (2008).
   PubMed Web of Science ®Google Scholar
• Gasparini M, Auricchio A, Metra M et al.; Multicentre Longitudinal Observational Study (MILOS) group. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio–ventricular junction ablation in patients with permanent atrial fibrillation. Eur. Heart J.29(13), 1644–1652 (2008).
   PubMed Web of Science ®Google Scholar
• Schutte F, Ludorff G, Grove R et al. Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation. Cardiol. J.16(3), 246–249 (2009).
   PubMed Web of Science ®Google Scholar
• Gervais R, Leclercq C, Shankar A et al. Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial. Eur. J. Heart Fail.11(7), 699–705 (2009).
   PubMed Web of Science ®Google Scholar
• Aranda JM Jr, Conti JB, Johnson JW et al. Cardiac resynchronization therapy in patients with heart failure and conduction abnormalities other than left bundle-branch block: analysis of the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Clin. Cardiol.27(12), 678–682 (2004).
   PubMed Web of Science ®Google Scholar
• Egoavil CA, Ho RT, Greenspon AJ, Pavri BB. Cardiac resynchronization therapy in patients with right bundle branch block: analysis of pooled data from the MIRACLE and Contak CD trials. Heart Rhythm2(6), 616–618 (2005).
   PubMed Web of Science ®Google Scholar
• Byrne MJ, Helm RH, Daya S et al. Diminished left ventricular dyssynchrony and impact of resynchronization in failing hearts with right versus left bundle branch block. J. Am. Coll. Cardiol.50(15), 1484–1490 (2007).
   PubMed Web of Science ®Google Scholar
• Adelstein EC, Saba S. Usefulness of baseline electrocardiographic QRS complex pattern to predict response to cardiac resynchronization. Am. J. Cardiol.103(2), 238–242 (2009).
   PubMed Web of Science ®Google Scholar
• Haghjoo M, Bagherzadeh A, Farahani MM. Significance of QRS morphology in determining the prevalence of mechanical dyssynchrony in heart failure patients eligible for cardiac resynchronization: particular focus on patients with right bundle branch block with and without coexistent left-sided conduction defects. Europace10, 566–571 (2008).
   PubMed Web of Science ®Google Scholar
• Bleeker GB, Schalij MJ, Holman ER, Steendijk P, van der Wall EE, Bax JJ. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy. Am. J. Cardiol.98, 230–235 (2006).
   PubMed Web of Science ®Google Scholar
• Abraham WT, Young JB, Leon AR et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation110, 2864–2868 (2004).
   PubMed Web of Science ®Google Scholar
• Cleland JG, Freemantle N, Daubert JC, Toff WD, Leisch F, Tavazzi L. Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study. Heart94(3), 278–283 (2008).
   PubMed Web of Science ®Google Scholar
• Linde C, Abraham WT, Gold MR et al.; the REVERSE study group. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J. Am. Coll. Cardiol.52(23), 1834–1843 (2008).
   PubMed Web of Science ®Google Scholar
• Daubert C, Gold MR, Abraham WT et al.; on behalf of the REVERSE study group. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction. Insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J. Am. Coll. Cardiol.54, 1837–1846 (2009).
   PubMed Web of Science ®Google Scholar
• Moss AJ, Hall WJ, Cannom DS et al. The MADIT-CRT trial investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N. Engl. J. Med.361(14), 1329–1338 (2009).
   PubMed Web of Science ®Google Scholar
• Yu C-M, Bleeker GB, Fung JW-H et al. Left ventricular reverse remodelling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation112, 1580–1586 (2005).
   PubMed Web of Science ®Google Scholar
• Chung ES, Katra RP, Ghio S et al. Cardiac resynchronization therapy in patients with left ventricular ejection fraction above 35%. J. Card. Fail.15(6), S62 (2009) (Abstract).
   Google Scholar
• Vardas P, Auricchio A, Blanc J-J et al. for the Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Guidelines for cardiac pacing and resynchronization therapy. Eur. Heart J.28, 2256–2295 (2007).
   PubMed Web of Science ®Google Scholar
• Epstein AE, DiMarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation117, e350–e408 (2008).
   PubMed Web of Science ®Google Scholar
• Marsan NA, Westenberg JJ, Ypenburg C et al. Magnetic resonance imaging and response to cardiac resynchronization therapy: relative merits of left ventricular dyssynchrony and scar tissue. Eur. Heart J.30(19), 2360–2367 (2009).
   PubMed Web of Science ®Google Scholar
• Riedlbauchova L, Brunken R, Jaber WA et al. The impact of myocardial viability on the clinical outcome of cardiac resynchronisation therapy. J. Cardiovasc. Electrophysiol.20, 50–57 (2009).
   PubMed Web of Science ®Google Scholar
• Butter C, Auricchio A, Stellbrink C et al.; on behalf of the PATH-CHF-II study group. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation104, 3026–3029 (2001).
   PubMed Web of Science ®Google Scholar
• Saxon LA, Olshansky B, Volosin K et al. Influence of left ventricular lead location on outcomes in the COMPANION study. J. Cardiovasc. Electrophysiol.20(7), 764–768 (2009).
   PubMed Web of Science ®Google Scholar